Exclusive: Drug that caused 'elephant man' side effect makes comeback after 2006 disaster

March 24, 2015 2:54 PM

18 0

LONDON (Reuters) - An experimental drug that caused appalling side effects in a clinical trial nine years ago is back in tests for rheumatoid arthritis and is showing promise when given at a fraction of the original dose.

The small German-Russian biotech firm which now owns the drug hopes to confirm its benefits in a mid-stage trial, starting in June, and then bring in a major pharmaceutical company as a strategic investor, its chief executive told Reuters.

Read more

To category page